ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $26,585 | +27.3% | 1,110 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $20,890 | +18.2% | 1,110 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $17,671 | +10.4% | 1,110 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $16,000 | 0.0% | 1,110 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $16,000 | -57.9% | 1,110 | -31.1% | 0.00% | -50.0% |
| Q4 2021 | $38,000 | +26.7% | 1,610 | -11.0% | 0.00% | +100.0% |
| Q3 2021 | $30,000 | -42.3% | 1,810 | -14.8% | 0.00% | -50.0% |
| Q2 2021 | $52,000 | +1633.3% | 2,125 | +2025.0% | 0.00% | – |
| Q1 2021 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |